Jeonju AgroBio-Materials Institute, Wonjangdong-gil 111-27, Deokjin-gu, Jeonju-si 54810, Jeollabuk-do, Republic of Korea.
Kookmin Bio Co., Ltd., 303, Cheonjam-ro, Wansan-gu, Jeonju-si 55069, Jeollabuk-do, Republic of Korea.
Nutrients. 2023 Jul 4;15(13):3029. doi: 10.3390/nu15133029.
The purpose of this study was to investigate the effect that hydrolyzed with enzymes from KMU01 has on dextran-sulfate-sodium (DSS)-induced colitis in mice. Hydrolysis improves functional health through the bioconversion of raw materials and increase in intestinal absorption rate and antioxidants. Therefore, was hydrolyzed in this study using a food-derived microorganism, and its anti-inflammatory effect was observed. Enzymatically hydrolyzed (EHG) was orally administered once daily for four weeks before DSS treatment. Colitis was induced in mice through the consumption of 5% (/) DSS in drinking water for eight days. The results showed that EHG treatment significantly alleviated DSS-induced body weight loss and decreased the disease activity index and colon length. In addition, EHG markedly reduced tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 production, and increased that of IL-10. EHG improved DSS-induced histological changes and intestinal epithelial barrier integrity in mice. Moreover, we found that the abundance of 15 microorganisms changed significantly; that of Proteobacteria and , which are upregulated in patients with Crohn's disease and ulcerative colitis, decreased after EHG treatment. These results suggest that EHG has a protective effect against DSS-induced colitis and is a potential candidate for colitis treatment.
本研究旨在探讨酶解产物对葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠的作用。水解通过生物转化原料、提高肠道吸收率和增加抗氧化剂来改善功能健康。因此,本研究使用一种来源于食物的微生物对进行了水解,并观察其抗炎作用。在 DSS 处理前,每天口服一次酶解(EHG),连续四周。通过饮用含 5%(/)DSS 的水 8 天诱导小鼠结肠炎。结果表明,EHG 治疗可显著减轻 DSS 诱导的体重减轻,并降低疾病活动指数和结肠长度。此外,EHG 还可显著降低肿瘤坏死因子-α、白细胞介素(IL)-1β 和 IL-6 的产生,增加 IL-10 的产生。EHG 改善了 DSS 诱导的小鼠组织学变化和肠道上皮屏障完整性。此外,我们发现 15 种微生物的丰度发生了显著变化;在克罗恩病和溃疡性结肠炎患者中上调的变形菌门和厚壁菌门的丰度在 EHG 治疗后降低。这些结果表明,EHG 对 DSS 诱导的结肠炎具有保护作用,是治疗结肠炎的潜在候选药物。